Short Interest in Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Increases By 300.0%

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 400 shares, a growth of 300.0% from the February 28th total of 100 shares. Based on an average trading volume of 3,200 shares, the short-interest ratio is presently 0.1 days.

Relief Therapeutics Stock Up 1.5 %

Shares of RLFTF opened at $2.64 on Friday. Relief Therapeutics has a 12-month low of $1.10 and a 12-month high of $7.66. The business has a 50-day simple moving average of $3.52 and a two-hundred day simple moving average of $4.45.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.